Support program for Chinese and Korean caregivers of dementia patients
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
This study is testing a support program for Chinese and Korean caregivers of family members with dementia to see if it helps them stay healthier and manage stress better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | New York University Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05461495 on ClinicalTrials.gov |
What this trial studies
This study tests a culturally tailored intervention designed to improve health outcomes for Chinese and Korean American caregivers of relatives with Alzheimer's disease and related dementias (ADRD). It involves a two-arm randomized controlled trial where participants will receive counseling and support through online chat groups and local support sessions. The study aims to assess the effectiveness of this intervention in reducing health risks associated with caregiving, particularly focusing on psychosocial factors and chronic conditions like diabetes and heart disease. A total of 300 caregivers will be enrolled from the New York and northern New Jersey area, with materials developed specifically for these communities.
Who should consider this trial
Good fit: Ideal candidates are Chinese or Korean American adults aged 50 and older who are primary caregivers for relatives with ADRD and have access to the internet.
Not a fit: Patients who do not identify as caregivers or are under 50 years of age may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the physical and mental health of caregivers, reducing their risk for chronic diseases.
How similar studies have performed: Previous studies have shown success with culturally tailored interventions for caregiver support, indicating potential for positive outcomes in this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A spouse or other family caregiver of Chinese or Korean ancestry living in New York City or Bergen County New Jersey, who is willing to participate in the study (additional family members can be included in family counseling sessions if the CG is assigned to the treatment group) * at least 50 years of age * self-identified as a primary caregiver * have access to Internet and phone with SMS and voice messaging * no plans to move for 12 months * able to read English, Chinese, or Korean * capable of completing informed consent * meet specific cardiometabolic and depressive symptom criteria: Cardiometabolic syndrome: It will not be required to submit objective measurement of cardiometabolic disorder, self-reported medical conditions will be accepted for enrollment. Diabetes: self-reported OR A1C \>= 5.7% OR High Cholesterol: self-reported OR low-density lipoprotein (LDL) \> 130 mg/dL or total cholesterol \> 200 mg/dL (American Heart Association 2018) OR Hypertension: self-reported OR systolic blood pressure (SBP) \>= 130 mmHg or diastolic blood pressure (DBP) \>= 80mmHg (2017 ACC/AHA hypertension guideline) OR Body Mass Index \> 23 kg/m2 by self-reported or measured height and weight (WHO expert consultation regarding Asian cut-off). Exclusion Criteria: * current alcoholic or substance abuse; and history of psychiatric diagnoses requiring hospitalization during the past 5 years.
Where this trial is running
New York, New York
- New York University — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Bei Wu, PhD — New York University
- Study coordinator: Eunjung Ko, PhD
- Email: ek3174@nyu.edu
- Phone: 212 992 3928
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.